Vaccinex (VCNX) Competitors $0.80 -0.08 (-9.23%) As of 06/11/2025 01:31 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VCNX vs. CDIO, PMCB, TSBX, APLM, MYNZ, GTBP, KTTA, OMGA, ALBT, and CHROShould you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Cardio Diagnostics (CDIO), PharmaCyte Biotech (PMCB), Turnstone Biologics (TSBX), Apollomics (APLM), Mainz Biomed (MYNZ), GT Biopharma (GTBP), Pasithea Therapeutics (KTTA), Omega Therapeutics (OMGA), Avalon GloboCare (ALBT), and Chromocell Therapeutics (CHRO). These companies are all part of the "pharmaceutical products" industry. Vaccinex vs. Its Competitors Cardio Diagnostics PharmaCyte Biotech Turnstone Biologics Apollomics Mainz Biomed GT Biopharma Pasithea Therapeutics Omega Therapeutics Avalon GloboCare Chromocell Therapeutics Vaccinex (NASDAQ:VCNX) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation. Do institutionals and insiders hold more shares of VCNX or CDIO? 50.1% of Vaccinex shares are held by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are held by institutional investors. 51.5% of Vaccinex shares are held by company insiders. Comparatively, 22.3% of Cardio Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is VCNX or CDIO more profitable? Vaccinex has a net margin of 0.00% compared to Cardio Diagnostics' net margin of -22,732.03%. Vaccinex's return on equity of 0.00% beat Cardio Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets VaccinexN/A N/A -383.58% Cardio Diagnostics -22,732.03%-258.85%-191.20% Do analysts recommend VCNX or CDIO? Cardio Diagnostics has a consensus price target of $60.00, indicating a potential upside of 1,418.99%. Given Cardio Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe Cardio Diagnostics is more favorable than Vaccinex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vaccinex 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cardio Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer VCNX or CDIO? In the previous week, Cardio Diagnostics had 5 more articles in the media than Vaccinex. MarketBeat recorded 5 mentions for Cardio Diagnostics and 0 mentions for Vaccinex. Cardio Diagnostics' average media sentiment score of 0.16 beat Vaccinex's score of 0.00 indicating that Cardio Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment Vaccinex Neutral Cardio Diagnostics Neutral Which has more volatility & risk, VCNX or CDIO? Vaccinex has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 3.12, meaning that its share price is 212% more volatile than the S&P 500. Does the MarketBeat Community believe in VCNX or CDIO? Vaccinex received 119 more outperform votes than Cardio Diagnostics when rated by MarketBeat users. However, 80.00% of users gave Cardio Diagnostics an outperform vote while only 60.00% of users gave Vaccinex an outperform vote. CompanyUnderperformOutperformVaccinexOutperform Votes12360.00% Underperform Votes8240.00% Cardio DiagnosticsOutperform Votes480.00% Underperform Votes120.00% Which has higher earnings and valuation, VCNX or CDIO? Cardio Diagnostics has lower revenue, but higher earnings than Vaccinex. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccinex$388K5.34-$20.25M-$48.27-0.02Cardio Diagnostics$19.90K345.14-$8.38MN/AN/A SummaryCardio Diagnostics beats Vaccinex on 10 of the 16 factors compared between the two stocks. Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VCNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCNX vs. The Competition Export to ExcelMetricVaccinexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.07M$6.92B$5.61B$8.62BDividend YieldN/A2.55%5.28%4.17%P/E Ratio-0.028.6727.1819.96Price / Sales5.34262.53412.23157.63Price / CashN/A65.8538.2534.64Price / Book-0.316.597.064.69Net Income-$20.25M$143.75M$3.23B$248.14M7 Day Performance-6.78%0.82%0.80%0.95%1 Month Performance-18.67%12.09%9.71%5.74%1 Year Performance-88.93%4.46%32.11%14.73% Vaccinex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCNXVaccinex0.3766 of 5 stars$0.80-9.2%N/A-88.5%$2.07M$388K-0.0240Gap DownCDIOCardio Diagnostics1.8156 of 5 stars$4.25+6.5%$60.00+1,311.8%-78.0%$7.39M$19.90K0.001Short Interest ↑Gap DownPMCBPharmaCyte Biotech1.1177 of 5 stars$1.07+4.3%N/A-54.3%$7.34MN/A2.024Positive NewsShort Interest ↑TSBXTurnstone Biologics3.3078 of 5 stars$0.31-4.5%$0.45+43.9%-87.4%$7.24M$19.31M-0.1082Positive NewsShort Interest ↓Gap DownAPLMApollomics0.8652 of 5 stars$6.55+7.4%N/A-68.7%$7.23M$1.22M0.0045Gap UpMYNZMainz Biomed2.8096 of 5 stars$2.04+1.5%$14.00+586.3%-92.5%$7.02M$893.99K-0.0330Positive NewsGap DownGTBPGT Biopharma2.7072 of 5 stars$2.71+5.0%$11.00+305.9%-5.4%$7.01MN/A-0.488Positive NewsShort Interest ↑Gap UpKTTAPasithea Therapeutics1.6395 of 5 stars$0.93-4.1%N/A-85.7%$6.92MN/A-0.093Short Interest ↓OMGAOmega Therapeutics2.0074 of 5 stars$0.13-21.8%$9.20+7,260.0%-94.1%$6.92M$8.10M-0.09120Upcoming EarningsGap UpALBTAvalon GloboCare2.2609 of 5 stars$3.64-1.1%N/A-59.0%$6.89M$1.37M-0.185Short Interest ↓CHROChromocell Therapeutics1.1965 of 5 stars$1.01+8.6%N/A+3.9%$6.63MN/A-0.814Short Interest ↓Gap Down Related Companies and Tools Related Companies CDIO Competitors PMCB Competitors TSBX Competitors APLM Competitors MYNZ Competitors GTBP Competitors KTTA Competitors OMGA Competitors ALBT Competitors CHRO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCNX) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
